3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
162
Myelodysplastic Syndromes
46
Leukemia, Myelomonocytic, Chronic
26
Leukemia
16
Myeloproliferative Disorders
11
Recurrence
9
Hematologic Neoplasms
8
Leukemia, Biphenotypic, Acute
7
Primary Myelofibrosis
6
Neoplasms
6
Lymphoma, T-Cell, Peripheral
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Anemia, Refractory, with Excess of Blasts
5
Neoplasm, Residual
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Monocytic, Acute
4
Hematologic Diseases
4
GATA2 Deficiency
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pathologic Complete Response
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hodgkin Disease
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Sarcoma
2
Interventions
Nivolumab
3
Oxaliplatin
2
Capecitabine
2
trifluridine tipiracil drug combination
1
sintilimab
1
relatlimab
1
regorafenib
1
dabrafenib
1
copanlisib
1
atezolizumab
1
Tiragolumab
1
Leucovorin
1
Immune Checkpoint Inhibitors
1
Fulvestrant
1
Fluorouracil
1
Cetuximab
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Spinocerebellar Degenerations
×
Azacitidine
×
1 year
×
Clear all
No trials found.